Johnson & Johnson (JNJ) Stock Price & Analysis
Johnson & Johnson (JNJ) fell 1.15% to USD 275.23 as of September 8, 2026 at 06:57 UTC, according to Nexqual real-time market data.
JNJ last closed at USD 275.23; the session ranged USD 274.75–277.8 on volume of 3,878,977 shares. Market capitalization is —, with a 52-week range of USD 173.33–281.07 (NYQ). Source: Nexqual, September 8, 2026 at 06:57 UTC.
Key Statistics (as of September 8, 2026 at 06:57 UTC)
| Price | USD 275.23 |
|---|---|
| Change | ▼ 1.15% (down) |
| Previous Close | USD 275.23 |
| Open | USD 275.23 |
| Day Range | USD 274.75 – 277.8 |
| 52-Week Range | USD 173.33 – 281.07 |
| Volume | 3,878,977 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (JNJ)
Nexqual's technical model rates JNJ "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:57 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.99 (neutral) |
| vs SMA50 | Above (USD 261.77) |
| MACD | 4.3 (positive) |
From Johnson & Johnson's Latest SEC 10-K Filing (filed 2026-02-11)
Partnerships
- In January 2026, the Company reached an agreement with the U.S.
- Many of these medicines were developed in collaboration with strategic partners or are licensed from other companies and maintain active lifecycle development programs.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PG | Procter & Gamble Company (The) | USD 146.44 | ▼ 0.81% |
| PFE | Pfizer, Inc. | USD 28.45 | ▼ 1.96% |
| MRK | Merck & Company, Inc. | USD 150.33 | ▼ 0.86% |
| KO | Coca-Cola Company (The) | USD 88.07 | ▼ 0.19% |
| XOM | ExxonMobil Holdings Corporation | USD 159.47 | ▼ 2.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:57 UTC. This page is informational and not investment advice.